Repligen Corporation Logo Image

Repligen Corporation

Repligen Corporation Banner Image

Most Recent Investor Fact Sheet

2013 Investor Fact Sheet

Repligen Corporation

Investor
Fact
Sheet

About Repligen Corporation

201-500 Employees
Based in Waltham, Massachusetts

Repligen Corporation (NASDAQ:RGEN) is a bioprocessing company focused on the development, manufacture and commercialization of highly innovative products used to improve the interconnected phases of the biological drug manufacturing process. Repligen's portfolio includes protein products (Protein A affinity ligands, cell culture growth factors), chromatography products (OPUS® pre-packed columns, chromatography resins, ELISA kits) and filtration products (XCell™ ATF Systems, TangenX™ Sius™ TFF cassettes). The company's bioprocessing products are sold to major life sciences companies, biopharmaceutical development companies and contract manufacturing organizations worldwide.

Ticker:
RGEN
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Investor Fact Sheets?

Search by company name or ticker symbol